Drugs / GW823093
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00372957 | Mar → Jun 2006 | type 2 diabetes mellitus | GlaxoSmithKline | Completed | Mixed |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | GW823093 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00372957 ↗ |
| Route | Oral | “administered Orally for 7 Days” NCT00372957 ↗ |